Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EU Committee reaches final decision on zinc oxide
The VMD has submitted evidence to support a proposal for a 10-year transition if products containing zinc oxide are withdrawn.

Pig farmers push for sensible transition period

The European Committee for Medicinal Products for Veterinary Use (CVMP) has reached a final decision that the benefit-risk for veterinary medicines containing zinc oxide is negative and that this class of products should be withdrawn.

The European Commission will now begin the formal decision making process and is expected to deliver its final decision sometime after June.

The Veterinary Medicines Directorate (VMD) has submitted evidence to support a proposal for a 10-year transition period if products containing zinc oxide are withdrawn.

This will allow for changes in pig farming practices to avoid increases in the occurrence of diarrhoea at weaning, to ensure animal welfare and prevent increases in the use of antibiotics.

Commenting, NPA chief executive Zoe Davis said she was ‘disappointed but hardly surprised' with the CVMP’s verdict. She explained that the association would now work with EU colleagues to ensure the industry is given enough time to adapt.

“As the Commission rarely go against CVMP advice, we will now need to lobby them hard for a sensible phase out period,” she said.

"While the VMD has submitted its response to the Commission consultation and suggested a 10-year phase-out period following our request, we will need to work with COPA and others to ensure the message is similar across the EU.

"We understand that several countries are in line with us already. We will also be seeking a meeting with the VMD to discuss the evidence on which this decision was made, look at the implications and explore options, particularly post-Brexit."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.